SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000879169-24-000158
Filing Date
2024-10-02
Accepted
2024-10-02 13:00:51
Documents
3
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1727888444.html 4  
1 FORM 4 wk-form4_1727888444.xml 4 3556
2 EX-24 harrigan-incytesection16.htm EX-24 3656
3 harrigan-incytesection16001.jpg GRAPHIC 247480
  Complete submission text file 0000879169-24-000158.txt   349936
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Issuer) CIK: 0000879169 (see all company filings)

IRS No.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
HARRIGAN EDMUND (Reporting) CIK: 0001177917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12400 | Film No.: 241346118